Gene: AUNIP
Official Full Name: aurora kinase A and ninein interacting proteinprovided by HGNC
Gene Summary: Enables damaged DNA binding activity. Involved in double-strand break repair via homologous recombination; negative regulation of double-strand break repair via nonhomologous end joining; and spindle organization. Located in centrosome; site of DNA damage; and spindle pole. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19529 | AUNIP Knockout cell line (HeLa) | Human | AUNIP | 1:3~1:6 | Negative | Online Inquiry |
KO19530 | AUNIP Knockout cell line (HCT 116) | Human | AUNIP | 1:2~1:4 | Negative | Online Inquiry |
KO19531 | AUNIP Knockout cell line (HEK293) | Human | AUNIP | 1:3~1:6 | Negative | Online Inquiry |
KO19532 | AUNIP Knockout cell line (A549) | Human | AUNIP | 1:3~1:4 | Negative | Online Inquiry |
AUNIP Gene Knockout Cell Lines are genetically modified cell lines designed to facilitate the study of gene function and the investigation of genetic diseases. Employing advanced CRISPR/Cas9 technology, these cell lines have been engineered to exhibit specific gene knockouts, allowing for the examination of the resulting phenotypic changes. This gene-editing technique provides a highly precise and efficient method for targeting genomic sequences, leading to the creation of cell lines that serve as invaluable tools for functional genomics research.
The primary mechanism of AUNIP Gene Knockout Cell Lines involves the introduction of double-strand breaks in specific target genes, leading to insertions or deletions during the DNA repair process. This targeted disruption enables researchers to explore gene function, investigate pathways relevant to disease processes, and evaluate the potential of therapeutic interventions. By utilizing these cell lines, scientists can derive meaningful insights into cellular mechanisms and explore how gene deficiencies affect cellular behavior and drug responses.
In research and clinical applications, AUNIP Gene Knockout Cell Lines play a crucial role in drug discovery, cancer research, and the study of genetic disorders. They provide an efficient platform for testing new therapeutics and understanding the molecular underpinnings of various diseases, ultimately facilitating the translation of basic research findings into clinical practice.
Compared to alternative products, AUNIP Gene Knockout Cell Lines offer enhanced specificity and efficiency in knocking out target genes, reducing off-target effects that can confound experimental results. Furthermore, these cell lines are validated and optimized for high-performance applications, ensuring reproducibility and reliability in experimental outcomes.
Researchers and clinicians alike will find AUNIP Gene Knockout Cell Lines to be of exceptional value, as they streamline the investigation of genetic function and gene-targeted therapies. These cell lines not only expedite the research process but also significantly contribute to the advancement of personalized medicine approaches.
Our company, a leader in innovative biotechnology solutions, specializes in providing high-quality genetically modified cell lines and other biological products tailored to meet the demands of cutting-edge research. With a strong commitment to scientific excellence and customer support, we equip researchers with the tools necessary to advance their work and drive impactful discoveries in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.